Pros and cons of drugs that prolong ventricular refractoriness.
Brachmann
J
J
Med. Univ. Klinik, Heidelberg, Germany.
Beyer
T
T
Schöls
W
W
Schmitt
C
C
Montero
M
M
Knollmann
W
W
Hilbel
T
T
Kübler
W
W
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D012032:Refractory Period, Electrophysiological / Q000187:drug effects*; D013610:Tachycardia / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents